Showing results (11-20 of 72) with videos related to
Sort By:
Pageof 8
JAMA Internal Medicine|April 5, 2013
Indications, complications, and management of inferior vena cava filters: the experience in 952 patients at an academic hospital with a level I trauma centerShayna Sarosiek, Mark Crowther, J Mark SloanTherapeutic Advances in Hematology|December 2, 2016
Review of siltuximab in the treatment of multicentric Castleman's diseaseShayna Sarosiek, Ruchit Shah, Nikhil C MunshiExpert Opinion on Drug Safety|March 1, 2021
Reducing treatment toxicity in Waldenström macroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J CastilloCurrent Treatment Options in Oncology|August 24, 2021
How to Sequence Therapies in Waldenström MacroglobulinemiaShayna Sarosiek, Steven P Treon, Jorge J CastilloHematological Oncology|June 15, 2025
Diagnosis and Management of Waldenstrom's MacroglobulinemiaSteven P Treon, Shayna Sarosiek, Jorge J CastilloCurrent Hematologic Malignancy Reports|December 16, 2024
Monoclonal Gammopathy-Associated NeuropathyShayna Sarosiek, Christopher T Doughty, Jorge J CastilloBlood|January 11, 2024
How I use genomics and BTK inhibitors in the treatment of Waldenström macroglobulinemiaSteven P Treon, Shayna Sarosiek, Jorge J CastilloAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 8, 2022
When a Monoclonal Gammopathy Is Not Multiple MyelomaBenjamin Derman, Jorge J Castillo, Shayna Sarosiek, et al.BMJ Case Reports|September 7, 2019
Haemodialysis-associated thrombocytopenia: interactions among the immune system, membranes and sterilisation methodsFelipe Batalini, Gabriel Francisco Aleixo, Asaf Maoz, et al.Cells|October 27, 2022
Coming of Age for BTK Inhibitor Therapy: A Review of Zanubrutinib in Waldenström MacroglobulinemiaJavier Muñoz, Jonas Paludo, Shayna Sarosiek, et al.Pageof 8